Medexus Pharmaceuticals Inc.
MEDXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $9 | $24 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12 | $12 | $13 | $14 |
| Inventory | $34 | $35 | $35 | $34 |
| Other Curr. Assets | $7 | $7 | $0 | $0 |
| Total Curr. Assets | $62 | $64 | $81 | $67 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $10 | $10 | $10 | $10 |
| Intangibles | $67 | $70 | $72 | $59 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $9 | $9 | $9 | $9 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $87 | $90 | $91 | $79 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $149 | $154 | $172 | $146 |
| Liabilities | – | – | – | – |
| Payables | $38 | $40 | $6 | $40 |
| Short-Term Debt | $21 | $22 | $37 | $18 |
| Tax Payable | $2 | $2 | $1 | $2 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $3 |
| Total Curr. Liab. | $75 | $79 | $97 | $66 |
| LT Debt | $0 | $0 | $0 | $22 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $22 | $22 | $22 | $24 |
| Total NC Liab. | $22 | $22 | $22 | $47 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $97 | $101 | $120 | $113 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $96 | $96 | $96 | $77 |
| Retained Earnings | -$62 | -$61 | -$62 | -$61 |
| AOCI | $6 | $6 | $6 | $6 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $52 | $53 | $52 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $149 | $154 | $172 | $146 |
| Net Debt | $12 | $13 | $13 | $31 |